215 related articles for article (PubMed ID: 35384527)
21. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
22. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
[TBL] [Abstract][Full Text] [Related]
23. Association of
Tjader NP; Beer AJ; Ramroop J; Tai MC; Ping J; Gandhi T; Dauch C; Neuhausen SL; Ziv E; Sotelo N; Ghanekar S; Meadows O; Paredes M; Gillespie J; Aeilts A; Hampel H; Zheng W; Jia G; Hu Q; Wei L; Liu S; Ambrosone CB; Palmer JR; Carpten JD; Yao S; Stevens P; Ho WK; Pan JW; Fadda P; Huo D; Teo SH; McElroy JP; Toland AE
medRxiv; 2023 Dec; ():. PubMed ID: 38106140
[TBL] [Abstract][Full Text] [Related]
24. Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives.
Wright N; Rida P; Rakha E; Agboola A; Aneja R
J Glob Oncol; 2018 Jul; 4():1-20. PubMed ID: 30085829
[TBL] [Abstract][Full Text] [Related]
25. Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancers.
Lee S; Kim HY; Jung YJ; Jung CS; Im D; Kim JY; Lee SM; Oh SH
Curr Probl Cancer; 2022 Apr; 46(2):100843. PubMed ID: 35180531
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.
Routh ED; Van Swearingen AED; Sambade MJ; Vensko S; McClure MB; Woodcock MG; Chai S; Cuaboy LA; Wheless A; Garrett A; Carey LA; Hoyle AP; Parker JS; Vincent BG; Anders CK
Front Oncol; 2022; 12():818693. PubMed ID: 35992833
[TBL] [Abstract][Full Text] [Related]
27. African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.
Martini R; Delpe P; Chu TR; Arora K; Lord B; Verma A; Bedi D; Karanam B; Elhussin I; Chen Y; Gebregzabher E; Oppong JK; Adjei EK; Jibril Suleiman A; Awuah B; Muleta MB; Abebe E; Kyei I; Aitpillah FS; Adinku MO; Ankomah K; Osei-Bonsu EB; Chitale DA; Bensenhaver JM; Nathanson DS; Jackson L; Petersen LF; Proctor E; Stonaker B; Gyan KK; Gibbs LD; Monojlovic Z; Kittles RA; White J; Yates CC; Manne U; Gardner K; Mongan N; Cheng E; Ginter P; Hoda S; Elemento O; Robine N; Sboner A; Carpten JD; Newman L; Davis MB
Cancer Discov; 2022 Nov; 12(11):2530-2551. PubMed ID: 36121736
[TBL] [Abstract][Full Text] [Related]
28. Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
Hoyer J; Vasileiou G; Uebe S; Wunderle M; Kraus C; Fasching PA; Thiel CT; Hartmann A; Beckmann MW; Lux MP; Reis A
BMC Cancer; 2018 Sep; 18(1):926. PubMed ID: 30257646
[TBL] [Abstract][Full Text] [Related]
29. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
[TBL] [Abstract][Full Text] [Related]
30. Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast Cancer.
Jin MS; Lee H; Woo J; Choi S; Do MS; Kim K; Song MJ; Kim Y; Park IA; Han D; Ryu HS
Proteomics Clin Appl; 2018 Sep; 12(5):e1700125. PubMed ID: 29476606
[TBL] [Abstract][Full Text] [Related]
31. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
Front Public Health; 2020; 8():576964. PubMed ID: 33415093
[TBL] [Abstract][Full Text] [Related]
32. Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
Yi D; Xu L; Luo J; You X; Huang T; Zi Y; Li X; Wang R; Zhong Z; Tang X; Li A; Shi Y; Rao J; Zhang Y; Sang J
Hum Genomics; 2019 Jan; 13(1):4. PubMed ID: 30630526
[TBL] [Abstract][Full Text] [Related]
33. Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.
Rajagopal T; Seshachalam A; Jothi A; Rathnam KK; Talluri S; Venkatabalasubranian S; Dunna NR
Mol Biol Rep; 2022 Apr; 49(4):3025-3032. PubMed ID: 35020120
[TBL] [Abstract][Full Text] [Related]
34. Inherited predisposition to breast cancer among African American women.
Churpek JE; Walsh T; Zheng Y; Moton Z; Thornton AM; Lee MK; Casadei S; Watts A; Neistadt B; Churpek MM; Huo D; Zvosec C; Liu F; Niu Q; Marquez R; Zhang J; Fackenthal J; King MC; Olopade OI
Breast Cancer Res Treat; 2015 Jan; 149(1):31-9. PubMed ID: 25428789
[TBL] [Abstract][Full Text] [Related]
35. Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer.
Wu J; Mamidi TKK; Zhang L; Hicks C
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30909550
[TBL] [Abstract][Full Text] [Related]
36. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
[TBL] [Abstract][Full Text] [Related]
37. Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene.
Niyomnaitham S; Parinyanitikul N; Roothumnong E; Jinda W; Samarnthai N; Atikankul T; Suktitipat B; Thongnoppakhun W; Limwongse C; Pithukpakorn M
PeerJ; 2019; 7():e6501. PubMed ID: 30828495
[TBL] [Abstract][Full Text] [Related]
38. Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.
Vaca-Paniagua F; Alvarez-Gomez RM; Maldonado-Martínez HA; Pérez-Plasencia C; Fragoso-Ontiveros V; Lasa-Gonsebatt F; Herrera LA; Cantú D; Bargallo-Rocha E; Mohar A; Durand G; Forey N; Voegele C; Vallée M; Le Calvez-Kelm F; McKay J; Ardin M; Villar S; Zavadil J; Olivier M
PLoS One; 2015; 10(5):e0126762. PubMed ID: 25961742
[TBL] [Abstract][Full Text] [Related]
39. Molecular analyses of triple-negative breast cancer in the young and elderly.
Aine M; Boyaci C; Hartman J; Häkkinen J; Mitra S; Campos AB; Nimeus E; Ehinger A; Vallon-Christersson J; Borg Å; Staaf J
Breast Cancer Res; 2021 Feb; 23(1):20. PubMed ID: 33568222
[TBL] [Abstract][Full Text] [Related]
40. A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients.
Seong MW; Kim KH; Chung IY; Kang E; Lee JW; Park SK; Lee MH; Lee JE; Noh DY; Son BH; Park HL; Cho SI; Park SS; ; Kim SW
Breast Cancer Res Treat; 2014 Jul; 146(1):63-9. PubMed ID: 24894343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
